Dr. Levy is the director of Cardiology Research, and also serves as program director of the Cardiology National Heart, Lung, and Blood Institute (NHLBI) Research Training Grant. His research interests are the pathophysiology of biomaterials used in medicine, basic mechanisms and novel therapies for heart valve disease, arterial angioplasty, local drug delivery, and nanomedicine. He also has experience over three decades in medical device development.
Dr. Rossano's extensive research experience primarily involves the epidemiology and outcomes of cardiovascular disease in children, and multi-institutional collaborative observational and interventional studies. His particular research interests include evaluating the treatment and outcomes of pediatric cardiomyopathy, heart failure, and transplantation.
Dr. Christopher Smith is an attending cardiologist at Children's Hospital of Philadelphia and an assistant professor of pediatrics at the Perelman School of Medicine of the University of Pennsylvania. His research focuses on developmental biology, interventional cardiology, and lymphatic intervention.
Dr. Jolley's research lab is focused on visualizing and quantifying congenitally abnormal heart structures using 3D imaging with the driving goal of informing surgical and interventional planning in children and adults with congenital heart disease.
Dr. Lindsay Rogers is an attending cardiologist with the Division of Cardiology and the director of Education for the Echocardiography Laboratory at CHOP. Her research focuses on non-invasive imaging and cardiac morphology, and neurodevelopmental outcomes in congenital heart disease.
Dr. O'Byrne is a pediatric cardiologist with research interests in cardiac disease outcomes, perioperative outcomes, and children with pulmonary hypertension. He combines the use of large observational datasets to study outcomes, practice variation, cost, and the determinants of health-related quality of life in this population.
Dr. Goldmuntz's research focuses on the genetic basis and modifiers of congenital heart disease, cardiomyopathy, and heart failure. Her goal is to identify genetic alterations conferring a risk for congenital heart disease and to correlate these findings with clinical outcomes. To this end, she is also performing clinical translational studies.
Dr. Avitabile works to understand the impact of musculoskeletal deficits on exercise performance in children with complex heart and lung diseases. She also participates in multi-centered clinical trials to advance the care of children with pediatric pulmonary hypertension.